Insider Transactions in Q1 2024 at Cigna Corp (CI)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 26
2024
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,761
+2.13%
|
$1,078,779
$139.22 P/Share
|
|
Mar 25
2024
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
31,209
-8.23%
|
$11,079,195
$355.17 P/Share
|
|
Mar 25
2024
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
31,209
+7.6%
|
$4,338,051
$139.22 P/Share
|
|
Mar 22
2024
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
6,338
-1.79%
|
$2,249,990
$355.11 P/Share
|
|
Mar 22
2024
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,338
+1.76%
|
$880,982
$139.22 P/Share
|
|
Mar 21
2024
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
2,293
-0.65%
|
$814,015
$355.02 P/Share
|
|
Mar 21
2024
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,293
+0.65%
|
$318,727
$139.22 P/Share
|
|
Mar 14
2024
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,616
+2.14%
|
$1,058,624
$139.22 P/Share
|
|
Mar 13
2024
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
13,761
-0.98%
|
$4,775,067
$347.22 P/Share
|
|
Mar 13
2024
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,761
+3.74%
|
$1,912,779
$139.22 P/Share
|
|
Mar 12
2024
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
2,238
-0.65%
|
$772,110
$345.0 P/Share
|
|
Mar 12
2024
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,238
+0.65%
|
$311,082
$139.22 P/Share
|
|
Mar 08
2024
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
2,801
-0.82%
|
$966,345
$345.19 P/Share
|
|
Mar 08
2024
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,801
+0.81%
|
$389,339
$139.22 P/Share
|
|
Mar 07
2024
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
2,412
-0.35%
|
$834,552
$346.04 P/Share
|
|
Mar 07
2024
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,412
+0.7%
|
$335,268
$139.22 P/Share
|
|
Mar 04
2024
|
Michael W Triplett Special Advisor |
SELL
Open market or private sale
|
Direct |
1,953
-5.68%
|
$648,396
$332.62 P/Share
|
|
Mar 04
2024
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
19,288
-5.36%
|
$6,403,616
$332.62 P/Share
|
|
Mar 04
2024
|
Nicole S Jones Officer |
SELL
Open market or private sale
|
Direct |
4,436
-12.31%
|
$1,472,752
$332.62 P/Share
|
|
Mar 01
2024
|
Hoeltzel Mary T Agoglia SVP Tax & Chief Acct. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
756
-11.88%
|
$251,748
$333.36 P/Share
|
|
Mar 01
2024
|
Hoeltzel Mary T Agoglia SVP Tax & Chief Acct. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,240
+27.06%
|
-
|
|
Mar 01
2024
|
Michael W Triplett Special Advisor |
SELL
Payment of exercise price or tax liability
|
Direct |
3,241
-4.37%
|
$1,079,253
$333.36 P/Share
|
|
Mar 01
2024
|
Michael W Triplett Special Advisor |
BUY
Grant, award, or other acquisition
|
Direct |
5,702
+13.15%
|
-
|
|
Mar 01
2024
|
Brian C Evanko Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,435
-6.14%
|
$1,809,855
$333.36 P/Share
|
|
Mar 01
2024
|
Brian C Evanko Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,329
+15.51%
|
-
|
|
Mar 01
2024
|
David J Brailer EVP & Chief Health Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,511
-7.17%
|
$503,163
$333.36 P/Share
|
|
Mar 01
2024
|
David J Brailer EVP & Chief Health Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,780
+20.41%
|
-
|
|
Mar 01
2024
|
David Cordani Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
22,930
-3.03%
|
$7,635,690
$333.36 P/Share
|
|
Mar 01
2024
|
David Cordani Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
35,946
+8.59%
|
-
|
|
Mar 01
2024
|
Noelle K Eder Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,838
-7.96%
|
$1,278,054
$333.36 P/Share
|
|
Mar 01
2024
|
Noelle K Eder Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,248
+20.1%
|
-
|
|
Mar 01
2024
|
Nicole S Jones Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,971
-6.2%
|
$1,655,343
$333.36 P/Share
|
|
Mar 01
2024
|
Nicole S Jones Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,268
+16.78%
|
-
|
|
Mar 01
2024
|
Eric P Palmer Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,638
-7.07%
|
$2,876,454
$333.36 P/Share
|
|
Mar 01
2024
|
Eric P Palmer Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,792
+16.89%
|
-
|
|
Feb 28
2024
|
Nicole S Jones Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,657
+7.51%
|
-
|
|
Feb 28
2024
|
Eric P Palmer Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,127
+9.27%
|
-
|
|
Feb 28
2024
|
Michael W Triplett Special Advisor |
BUY
Grant, award, or other acquisition
|
Direct |
1,709
+5.08%
|
-
|
|
Feb 28
2024
|
Noelle K Eder Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,657
+12.51%
|
-
|
|
Feb 28
2024
|
David J Brailer EVP & Chief Health Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,121
+27.91%
|
-
|
|
Feb 28
2024
|
David Cordani Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
9,927
+2.78%
|
-
|
|
Feb 28
2024
|
Brian C Evanko Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,127
+12.16%
|
-
|
|
Feb 27
2024
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
2,000
-0.59%
|
$690,000
$345.04 P/Share
|
|
Feb 27
2024
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+0.59%
|
$278,000
$139.22 P/Share
|
|
Feb 26
2024
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
10,453
-1.01%
|
$3,616,738
$346.28 P/Share
|
|
Feb 26
2024
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,453
+2.92%
|
$1,452,967
$139.22 P/Share
|
|
Feb 23
2024
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
6,319
-1.84%
|
$2,180,055
$345.24 P/Share
|
|
Feb 23
2024
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,319
+1.81%
|
$878,341
$139.22 P/Share
|
|
Feb 16
2024
|
William J De Laney Iii Director |
SELL
Bona fide gift
|
Direct |
3,376
-16.57%
|
-
|
|
Feb 15
2024
|
Eric P Palmer Officer |
BUY
Bona fide gift
|
Indirect |
312
+17.84%
|
-
|